In this episode of the Oncology Insights Podcast, host Dr. Petros Grivas is joined by Dr. Stanley Riddell, one of the world's leading pioneers of cancer immunotherapy and a longtime physician-scientist at Fred Hutch. Dr. Riddell's career traces the remarkable evolution of immunotherapy, from the early days of bone marrow transplantation to the development of genetically engineered T-cell therapies that are transforming cancer care today.

Main Topics:

1. Dr. Riddell's career path and contributions to immunotherapy

2. Development and clinical success of CAR T cell therapy

3. Challenges of translating immunotherapy from lab to clinic

4. Future of cancer treatment and possibilities for solid tumors

5. Collaboration between academia, industry, and global health equity

6. The importance of perseverance and impactful research

Timestamps:

1. 00:00 - Introduction to Dr. Stanley Riddell and his contributions to immunotherapy

2. 02:00 - Early career: Stem cell transplant and immunology breakthroughs

3. 05:00 - Overcoming infectious complications in transplant patients

4. 08:00 - Development of CMV-specific T cells and initial cancer applications

5. 11:00 - The birth and growth of CAR T cell therapy at Fred Hutch

6. 12:50 - Clinical successes and ongoing challenges in CAR T treatments

7. 15:00 - Industry collaborations and commercialization efforts

8. 16:00 - Implementing CAR T therapies in community settings and future innovations

9. 18:00 - Addressing healthcare disparities globally

10. 20:00 - The infrastructure at Fred Hutch supporting cutting-edge research

11. 23:00 - The promising future of biomedical science and immunology

12. 25:00 - Role of funding and federal support in sustaining innovation

13. 26:00 - Potential of immunotherapy in solid tumors and personalized medicine

14. 28:00 - Final thoughts: hope for curing more patients and improving quality of life

Resources & Links:

Stan Riddell Faculty Bio: https://www.fredhutch.org/en/faculty-lab-directory/riddell-stanley.html